February 9, 2026 · Form 4 insider transaction
Salas Eduardo Rene bought 17,730 shares of ADMA Biologics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.